Target intelligence / Profile preview

Tetanus neurotoxin (TeNT) (TeNT)

Target
TeNT
Molecular classification
Bacterial toxin, Zinc metalloprotease, Neurotoxin
01

Overview

Tetanus neurotoxin (TeNT), or tetanospasmin, is a highly potent AB-type protein toxin secreted by the anaerobic bacterium Clostridium tetani (UniProt: P04958). It is the primary etiologic agent of tetanus, a severe neurological condition marked by generalized muscle rigidity and painful spasms due to the loss of inhibitory control in the central nervous system (StatPearls: Tetanus, 2023). The toxin is composed of a 100 kDa heavy chain (H-chain) responsible for neuronal binding and a 50 kDa light chain (L-chain) that acts as a zinc-dependent metalloprotease. Following internalization and retrograde axonal transport to the spinal cord, the L-chain specifically cleaves synaptobrevin-2 (VAMP2), thereby blocking the release of inhibitory neurotransmitters such as glycine and GABA (NCBI: PMC3133546). Antigenic epitopes, particularly those located on the C-terminal domain of the heavy chain, are the critical targets for neutralizing antibodies. Vaccines utilize an inactivated form of the toxin, known as tetanus toxoid, to stimulate the immune system to recognize these epitopes and provide long-term protection, while tetanus immune globulin is used for immediate passive neutralization of the toxin (CDC: Tetanus Vaccination, 2022).

Other names
TetanospasminClostridium tetani neurotoxinTeNTTeLTetanus toxoidTetanus toxin antigenic epitopes
02

Mechanism of action

Tetanus toxoid vaccines induce active immunity by stimulating B-cells to produce neutralizing IgG antibodies that recognize and bind to specific antigenic epitopes on the tetanus toxin (CDC: Tetanus Vaccination, 2022). These antibodies prevent the toxin from binding to its receptors on neuronal membranes, thereby neutralizing its toxic effects. Tetanus immune globulin (TIG) provides passive immunity by delivering pre-formed antibodies that bind to circulating toxin epitopes, preventing further neuronal uptake (StatPearls: Tetanus, 2023).

03

Biological functions

ProteolysisInhibition of neurotransmitter releaseRetrograde axonal transportSynaptic vesicle trafficking interference
04

Disease associations

TetanusInfection
05

Safety considerations

Hypersensitivity reactionsArthus-type reactionInjection site painBrachial neuritis
06

Interacting drugs

Tetanus toxoid

2 more in the full profile.

07

Biomarkers

Anti-tetanus IgG antibody titer

Beyond the preview

Go deeper on Tetanus neurotoxin (TeNT) (TeNT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetanus neurotoxin (TeNT) (TeNT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call